OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 1, pp. 3-11
Closed Access | Times Cited: 98
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 1, pp. 3-11
Closed Access | Times Cited: 98
Showing 26-50 of 98 citing articles:
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
Antonio Travaglino, Antonio Raffone, Diego Raimondo, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 158, Iss. 1, pp. 13-20
Open Access | Times Cited: 38
Antonio Travaglino, Antonio Raffone, Diego Raimondo, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 158, Iss. 1, pp. 13-20
Open Access | Times Cited: 38
Molecular testing for endometrial cancer: An SGO clinical practice statement
Christine Walsh, Kari Hacker, Angeles Alvarez Secord, et al.
Gynecologic Oncology (2022) Vol. 168, pp. 48-55
Closed Access | Times Cited: 26
Christine Walsh, Kari Hacker, Angeles Alvarez Secord, et al.
Gynecologic Oncology (2022) Vol. 168, pp. 48-55
Closed Access | Times Cited: 26
Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma
Antonio Raffone, Antonio Travaglino, Diego Raimondo, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 2, pp. 621-628
Closed Access | Times Cited: 32
Antonio Raffone, Antonio Travaglino, Diego Raimondo, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 2, pp. 621-628
Closed Access | Times Cited: 32
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer
Arnaud Da Cruz Paula, Deborah F. DeLair, Lorenzo Ferrando, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 2, pp. 535-544
Open Access | Times Cited: 30
Arnaud Da Cruz Paula, Deborah F. DeLair, Lorenzo Ferrando, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 2, pp. 535-544
Open Access | Times Cited: 30
Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis
Antonio Travaglino, Antonio Raffone, Angela Santoro, et al.
Gynecologic Oncology (2021) Vol. 162, Iss. 3, pp. 804-808
Closed Access | Times Cited: 28
Antonio Travaglino, Antonio Raffone, Angela Santoro, et al.
Gynecologic Oncology (2021) Vol. 162, Iss. 3, pp. 804-808
Closed Access | Times Cited: 28
The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
Amélia Favier, Justine Varinot, Cathérine Uzan, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3783-3783
Open Access | Times Cited: 22
Amélia Favier, Justine Varinot, Cathérine Uzan, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3783-3783
Open Access | Times Cited: 22
Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups
Lina Irshaid, Danielle C. Costigan, Fei Dong, et al.
Modern Pathology (2023) Vol. 36, Iss. 5, pp. 100123-100123
Open Access | Times Cited: 12
Lina Irshaid, Danielle C. Costigan, Fei Dong, et al.
Modern Pathology (2023) Vol. 36, Iss. 5, pp. 100123-100123
Open Access | Times Cited: 12
Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
Amy Jamieson, Melissa K. McConechy, Amy Lum, et al.
Gynecologic Oncology (2023) Vol. 175, pp. 45-52
Closed Access | Times Cited: 12
Amy Jamieson, Melissa K. McConechy, Amy Lum, et al.
Gynecologic Oncology (2023) Vol. 175, pp. 45-52
Closed Access | Times Cited: 12
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
Amy Jamieson, Lisa Barroilhet, Jessica N. McAlpine
Cancer (2022) Vol. 128, Iss. 15, pp. 2853-2857
Closed Access | Times Cited: 19
Amy Jamieson, Lisa Barroilhet, Jessica N. McAlpine
Cancer (2022) Vol. 128, Iss. 15, pp. 2853-2857
Closed Access | Times Cited: 19
Controversies in the Management of Clear Cell Carcinoma of the Uterus and Ovary
Manavi Sachdeva, Félix Blanc‐Durand, David S.P. Tan
International Journal of Gynecological Cancer (2025) Vol. 35, Iss. 3, pp. 101681-101681
Open Access
Manavi Sachdeva, Félix Blanc‐Durand, David S.P. Tan
International Journal of Gynecological Cancer (2025) Vol. 35, Iss. 3, pp. 101681-101681
Open Access
Primary Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma
Harsimar Kaur, Lawrence Hsu Lin, David L. Kolin, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Harsimar Kaur, Lawrence Hsu Lin, David L. Kolin, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement
Nicha Assavapokee, Uraiwan Khomphaiboonkij, Siriwan Tangjitgamol, et al.
Journal of Gynecologic Oncology (2025) Vol. 36
Open Access
Nicha Assavapokee, Uraiwan Khomphaiboonkij, Siriwan Tangjitgamol, et al.
Journal of Gynecologic Oncology (2025) Vol. 36
Open Access
FRα expression in advanced endometrial carcinoma: Clinicopathological, molecular, and prognosis correlates
Yinbo Xiao, Junyi Pang, Yang Zhou, et al.
Gynecologic Oncology (2025) Vol. 197, pp. 146-154
Closed Access
Yinbo Xiao, Junyi Pang, Yang Zhou, et al.
Gynecologic Oncology (2025) Vol. 197, pp. 146-154
Closed Access
Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier
Jutta Huvila, Katri Orte, Paula Vainio, et al.
Human Pathology (2021) Vol. 111, pp. 98-109
Open Access | Times Cited: 22
Jutta Huvila, Katri Orte, Paula Vainio, et al.
Human Pathology (2021) Vol. 111, pp. 98-109
Open Access | Times Cited: 22
Grading of endometrial cancer using 1H HR-MAS NMR-based metabolomics
Agnieszka Skorupa, Michał Poński, Mateusz Ciszek, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Agnieszka Skorupa, Michał Poński, Mateusz Ciszek, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
Gian Franco Zannoni, Emma Bragantini, Francesca Castiglione, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Gian Franco Zannoni, Emma Bragantini, Francesca Castiglione, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas
Liju Zong, Shengwei Mo, Zezheng Sun, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 530-530
Open Access | Times Cited: 9
Liju Zong, Shengwei Mo, Zezheng Sun, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 530-530
Open Access | Times Cited: 9
The Evolving Landscape of Immunotherapy in Uterine Cancer: A Comprehensive Review
Bashar Haj Hamoud, Romina‐Marina Sima, Ileana Adela Văcăroiu, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1502-1502
Open Access | Times Cited: 9
Bashar Haj Hamoud, Romina‐Marina Sima, Ileana Adela Văcăroiu, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1502-1502
Open Access | Times Cited: 9
Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis
Ana Luzarraga Aznar, Vicente Bebia, Natalia R. Gómez-Hidalgo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1768-1778
Closed Access | Times Cited: 3
Ana Luzarraga Aznar, Vicente Bebia, Natalia R. Gómez-Hidalgo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1768-1778
Closed Access | Times Cited: 3
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Regina Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 3988-3988
Open Access | Times Cited: 19
Regina Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 3988-3988
Open Access | Times Cited: 19
TERT promoter mutations and gene amplification in endometrial cancer
Aaron Praiss, Antonio Marra, Qin Zhou, et al.
Gynecologic Oncology (2023) Vol. 179, pp. 16-23
Closed Access | Times Cited: 8
Aaron Praiss, Antonio Marra, Qin Zhou, et al.
Gynecologic Oncology (2023) Vol. 179, pp. 16-23
Closed Access | Times Cited: 8
The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
Qing Wu, Nianhai Zhang, Xianhe Xie
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Qing Wu, Nianhai Zhang, Xianhe Xie
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network
Elsa Nigon, Claudia Lefeuvre‐Plesse, Alejandra Martínez, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Elsa Nigon, Claudia Lefeuvre‐Plesse, Alejandra Martínez, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Evaluation of prognostic potential of β-catenin and L1CAM expression according to endometrial cancer risk group
Heesoo Yoon, Dong Hoon Suh, Kidong Kim, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 132-138
Closed Access | Times Cited: 2
Heesoo Yoon, Dong Hoon Suh, Kidong Kim, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 132-138
Closed Access | Times Cited: 2
Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications
Elisabetta Kuhn, Donatella Gambini, Letterio Runza, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2458-2458
Open Access | Times Cited: 2
Elisabetta Kuhn, Donatella Gambini, Letterio Runza, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2458-2458
Open Access | Times Cited: 2
